DB

David M. Burns

IN Incyte: 40 patents #18 of 356Top 6%
3M: 23 patents #543 of 11,543Top 5%
SI Sunnybrook Research Institute: 2 patents #26 of 130Top 20%
Motorola Mobility: 1 patents #941 of 2,091Top 50%
Overall (All Time): #32,604 of 4,157,543Top 1%
66
Patents All Time

Issued Patents All Time

Showing 25 most recent of 66 patents

Patent #TitleCo-InventorsDate
12421197 Aminopyrazine derivatives as PI3K-γ inhibitors Brent Douty, Yanran Ai, Andrew P. Combs, Nikoo Falahatpisheh, Daniel Levy +6 more 2025-09-23
12415809 Pyrrolotriazine compounds as tam inhibitors Yun-Long Li, Xiaozhao Wang, Joseph Barbosa, Hao Feng, Joseph Glenn +4 more 2025-09-16
12370053 Systems and methods for surgical implant guidance and positioning with optical surface imaging Cari Marisa Whyne, Normand Robert 2025-07-29
12173006 Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor Brent Douty, Andrew P. Combs, Zhongjiang Jia, Daniel Levy, Eddy W. Yue 2024-12-24
12084449 Imidazotriazines and imidazopyrimidines as kinase inhibitors Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more 2024-09-10
12030885 Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors Andrew W. Buesking, Richard B. Sparks, Andrew P. Combs, Brent Douty, Nikoo Falahatpisheh +5 more 2024-07-09
11976073 Bicyclic amines as CDK2 inhibitors Joshua Hummel, Ding-Quan Qian, Xiaozhao Wang 2024-05-07
11926630 Tertiary alcohols as PI3K-γ inhibitors Brent Douty, Andrew W. Buesking, Andrew P. Combs, Nikoo Falahatpisheh, Ravi Kumar Jalluri +7 more 2024-03-12
11780840 Tricyclic urea compounds as JAK2 V617F inhibitors Yanran Ai, Onur Atasoylu, Yu Sheng Bai, Joseph Barbosa, Daniel Levy +11 more 2023-10-10
11589997 Systems and methods for surgical implant guidance and positioning with optical surface imaging Cari Marisa Whyne, Normand Robert 2023-02-28
11261191 Imidazotriaines and imidazopyrimidines as kinase inhibitors Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more 2022-03-01
11225486 Tertiary alcohols as PI3K-γ inhibitors Brent Douty, Andrew W. Buesking, Andrew P. Combs, Nikoo Falahatpisheh, Ravi Kumar Jalluri +7 more 2022-01-18
11214573 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors Wenqing Yao, Jincong Zhuo 2022-01-04
11186580 Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor Brent Douty, Andrew P. Combs, Zhongjiang Jia, Daniel Levy, Eddy W. Yue 2021-11-30
11136326 Pyrrolopyrimidine derivatives as TAM inhibitors Yun-Long Li, Hao Feng, Joseph Glenn, Chunhong He, Song Mei +3 more 2021-10-05
11046658 Aminopyrazine derivatives as PI3K-γ inhibitors Brent Douty, Yanran Ai, Andrew P. Combs, Nikoo Falahatpisheh, Daniel Levy +6 more 2021-06-29
10975088 Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors Andrew W. Buesking, Richard B. Sparks, Andrew P. Combs, Brent Douty, Nikoo Falahatpisheh +5 more 2021-04-13
10738052 Imidazotriaines and imidazopyrimidines as kinase inhibitors Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more 2020-08-11
10738057 Tertiary alcohols as PI3K-γ inhibitors Brent Douty, Andrew W. Buesking, Andrew P. Combs, Nikoo Falahatpisheh, Ravi Kumar Jalluri +7 more 2020-08-11
10598823 Films including triazine-based ultraviolet absorbers David W. Meitz, Bimal V. Thakkar, David B. Olson, Lee A. Pavelka 2020-03-24
10519163 Pyrrolopyrimidine derivatives as TAM inhibitors Yun-Long Li, Hao Feng, Joseph Glenn, Chunhong He, Song Mei +3 more 2019-12-31
10513522 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors Wenqing Yao, Jincong Zhuo 2019-12-24
10479795 Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors Andrew W. Buesking, Richard B. Sparks, Andrew P. Combs, Brent Douty, Nikoo Falahatpisheh +5 more 2019-11-19
10053465 Pyrrolopyrimidine derivatives as TAM inhibitors Yun-Long Li, Hao Feng, Joseph Glenn, Chunhong He, Taisheng Huang +4 more 2018-08-21
10005788 Bicyclic fused pyrimidine compounds as TAM inhibitors Yun-Long Li 2018-06-26